Here's why Needham upgraded stock to buy
Hosted on MSN18h
Needham downgrades Biogen on slow growth of Alzheimer's drugInvesting.com - Needham downgraded Biogen Inc (NASDAQ:BIIB) on Monday, citing slower-than-expected growth for its Alzheimer ...
Needham analyst John Todaro raised the firm’s price target on Coinbase (COIN) to $375 from $290 and keeps a Buy rating on the shares. The firm ...
A spacious historic house located at 113 Hunnewell Street in Needham Heights has a new owner. The 3,907-square-foot property, ...
A 17-year-old girl from Massachusetts died in a crash in Shrewsbury, Vermont, on Sunday, officials say. At 4:06 a.m., ...
Needham downgraded Biogen (BIIB) to Hold from Buy without a price target The firm does not see a meaningful source of upside for the shares ...
Biogen downgraded to Hold by Needham amid projected flat revenues until 2026. Leqembi and other new product sales show ...
NEEDHAM -- While their offense certainly left its mark, it was No. 4 Needham’s defense that earned them the 31-7 win over No.
A year ago, Needham’s Greta Hammer was outside the ropes watching the MIAA Meet of Champions. On Saturday at Willard Park, ...
The eVTOL sector continues to rally as investors eye the FAA approvals needed by the major players to begin operations in the U.S. Needham analyst Chris Pierce noted that the FAA has signaled the long ...
Needham Aggressive Growth Fund earns an Above Average Process Pillar rating. The most important driver of the rating is the fund's impressive long-term risk-adjusted performance. This can be seen ...
The brush fire battle continued Tuesday with a red flag warning in effect for Massachusetts again. Flames spread overnight at ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback